Neuropeptide‐Y levels in ST‐segment–elevation myocardial infarction: relationship with coronary microvascular function, heart failure, and mortality
<strong>Background<br></strong> The sympathetic cotransmitter, neuropeptide Y (NPY), is released into the coronary sinus during ST‐segment–elevation myocardial infarction and can constrict the coronary microvasculature. We sought to establish whether peripheral venous (PV) NPY leve...
Main Authors: | Gibbs, T, Tapoulal, N, Shanmuganathan, M, Burrage, MK, Borlotti, A, Banning, AP, Choudhury, RP, Neubauer, S, Kharbanda, RK, Ferreira, VM, Channon, KM, Herring, N |
---|---|
Other Authors: | OxAMI (Oxford Acute Myocardial Infarction) Study |
Format: | Journal article |
Language: | English |
Published: |
American Heart Association
2022
|
Similar Items
-
Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction
by: Herring, N, et al.
Published: (2019) -
Impaired myocardial healing in patients with diabetes after ST-elevation myocardial infarction
by: Wamil, M, et al.
Published: (2019) -
Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction
by: Cuculi, F, et al.
Published: (2013) -
Pressure-bounded coronary flow reserve to assess the extent of microvascular dysfunction in patients with ST-elevation acute myocardial infarction
by: Scarsini, R, et al.
Published: (2019) -
The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade
by: Kalla, M, et al.
Published: (2019)